DAFNA Capital Management LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 125 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2014$2,595,000
+42.1%
514,853
+50.3%
2.23%
+18.7%
Q4 2013$1,826,000
+165.8%
342,453
+89.0%
1.88%
+150.2%
Q3 2013$687,000181,1530.75%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 2,244,080$12,096,0004.51%
ALTFEST L J & CO INC 39,491$1,653,0001.15%
GARRISON BRADFORD & ASSOCIATES INC 82,700$446,0000.44%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,074,557$48,912,0000.40%
Virtus ETF Advisers LLC 87,477$472,0000.35%
Cannell & Co. 1,614,678$8,703,0000.32%
Birchview Capital, LP 44,000$237,0000.17%
STONERIDGE INVESTMENT PARTNERS LLC 180,534$973,0000.14%
HighPoint Advisor Group LLC 8,484$344,0000.12%
MARINER INVESTMENT GROUP LLC 63,090$340,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders